170 related articles for article (PubMed ID: 15457424)
1. Ileus following total hip or knee arthroplasty is associated with increased risk of deep venous thrombosis and pulmonary embolism.
Berend KR; Lombardi AV; Mallory TH; Dodds KL; Adams JB
J Arthroplasty; 2004 Oct; 19(7 Suppl 2):82-6. PubMed ID: 15457424
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty.
Sarmiento A; Goswami AD
J Bone Joint Surg Am; 1999 Mar; 81(3):339-46. PubMed ID: 10199271
[TBL] [Abstract][Full Text] [Related]
6. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
[TBL] [Abstract][Full Text] [Related]
8. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
Colwell CW
Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
[TBL] [Abstract][Full Text] [Related]
9. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study.
Sudo A; Sano T; Horikawa K; Yamakawa T; Shi D; Uchida A
J Orthop Surg (Hong Kong); 2003 Dec; 11(2):174-7. PubMed ID: 14676343
[TBL] [Abstract][Full Text] [Related]
10. The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol.
Westrich GH; Farrell C; Bono JV; Ranawat CS; Salvati EA; Sculco TP
J Arthroplasty; 1999 Jun; 14(4):456-63. PubMed ID: 10428226
[TBL] [Abstract][Full Text] [Related]
11. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2002 May; 96(5):1140-6. PubMed ID: 11981154
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty.
Lyman S; Sherman S; Carter TI; Bach PB; Mandl LA; Marx RG
Clin Orthop Relat Res; 2006 Jul; 448():152-6. PubMed ID: 16826110
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty.
Hooker JA; Lachiewicz PF; Kelley SS
J Bone Joint Surg Am; 1999 May; 81(5):690-6. PubMed ID: 10360697
[TBL] [Abstract][Full Text] [Related]
14. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
15. Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin.
Berend KR; Lombardi AV
Am J Orthop (Belle Mead NJ); 2006 Jan; 35(1):24-9. PubMed ID: 16475420
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
Nagase Y; Yasunaga H; Horiguchi H; Hashimoto H; Shoda N; Kadono Y; Matsuda S; Nakamura K; Tanaka S
J Bone Joint Surg Am; 2011 Dec; 93(24):e146. PubMed ID: 22258781
[TBL] [Abstract][Full Text] [Related]
17. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic complications after total hip replacement.
Borghi B; Casati A;
Int Orthop; 2002; 26(1):44-7. PubMed ID: 11954849
[TBL] [Abstract][Full Text] [Related]
19. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
20. Surveillance venous duplex is not clinically useful after total joint arthroplasty when effective deep venous thrombosis prophylaxis is used.
Schwarcz TH; Matthews MR; Hartford JM; Quick RC; Kwolek CJ; Minion DJ; Endean ED; Mentzer RM
Ann Vasc Surg; 2004 Mar; 18(2):193-8. PubMed ID: 15253255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
